Although the expression was reduced in approximately 85% of the adenomas, hypermethylation of CKDN2A and CDKN2B promoter regions was found in a much smaller proportion implying that other mechanism may be involved in CDKN2A and CDKN2Breduced expressions. This evidence concerns the gene CDKN2B and adenoma.